State Street
LENZ

State Street’s LENZ Therapeutics LENZ Stock Holding History

State Street’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Buy
406,674
+4,449
+1% +$35.9K ﹤0.01% 3295
2026
Q1 		$3.68M Sell
402,225
-108,524
-21% -$1.52M ﹤0.01% 3077
2025
Q4 		$8.17M Buy
510,749
+92,765
+22% +$2.7M ﹤0.01% 2747
2025
Q3 		$19.5M Buy
417,984
+42,256
+11% +$1.55M ﹤0.01% 2269
2025
Q2 		$11M Buy
375,728
+88,372
+31% +$2.4M ﹤0.01% 2540
2025
Q1 		$7.39M Sell
287,356
-206,960
-42% -$5.1M ﹤0.01% 2708
2024
Q4 		$14.3M Buy
494,316
+205,162
+71% +$6.25M ﹤0.01% 2423
2024
Q3 		$6.86M Buy
289,154
+45,600
+19% +$1.01M ﹤0.01% 2810
2024
Q2 		$4.21M Buy
243,554
+178,410
+274% +$3.12M ﹤0.01% 3000
2024
Q1 		$1.45M Buy
65,144
+3,077
+5% +$64K ﹤0.01% 3380
2023
Q4 		$1.14M Sell
62,067
-285
-0.5% -$4.71K ﹤0.01% 3457
2023
Q3 		$1.08M Sell
62,352
-643
-1% -$11.2K ﹤0.01% 3512
2023
Q2 		$1.15M Buy
62,995
+50,259
+395% +$1M ﹤0.01% 3561
2023
Q1 		$218K Hold
12,736
– – ﹤0.01% 4050
2022
Q4 		$296K Buy
12,736
+5,957
+88% +$138K ﹤0.01% 3948
2022
Q3 		$150K Hold
6,779
– – ﹤0.01% 4262
2022
Q2 		$130K Sell
6,779
-39,277
-85% -$876K ﹤0.01% 4398
2022
Q1 		$1.64M Buy
46,056
+9,416
+26% +$589K ﹤0.01% 3643
2021
Q4 		$3.19M Buy
36,640
+8,548
+30% +$708K ﹤0.01% 3468
2021
Q3 		$3.22M Buy
+28,092
New +$4.16M ﹤0.01% 3460

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

State Street's LENZ Position: Q2 2026 in Review

State Street increased its LENZ Therapeutics (LENZ) stake by 1.1% in Q2 2026, buying an estimated $35.9K and bringing the position to 406,674 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3295.

State Street first reported a position in LENZ in Q3 2021 and has held it in 20 quarters since. The position peaked at $19.5M in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • State Street held 406,674 shares of LENZ Therapeutics worth $2.31M as of Q2 2026.
  • State Street bought 4,449 LENZ Therapeutics shares in Q2 2026, an estimated $35.9K.
  • LENZ Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3295 holding.
  • State Street first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • State Street's LENZ Therapeutics position peaked at $19.5M in Q3 2025.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.